Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: Pool-analysis of phase III randomized clinical trials
Author:
Publisher
Elsevier BV
Subject
Hematology
Reference22 articles.
1. Prevention of venous thromboembolism;Geerts,2008
2. Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development;Ufer;Thromb Haemost,2010
3. Assessing the safety profiles of new anticoagulants for major orthopaedic surgery thromboprophylaxis;Hull;Clin Appl Thromb Hemost,2009
4. for the RE-MODEL Study Group. Oral dabigatran etexilate vs. subcutaneous enoxaparin for thromboembolism prevention after total knee replacement: the RE-MODEL randomised trial;Eriksson;J Thromb Haemost,2007
5. RE-MOBILIZE Writing Committee. The oral thrombin inhibitor dabigatran etexilate vs the North American enoxaparin regimen for prevention of venous thromboembolism after knee arthroplasty surgery;Ginsberg;J Arthroplasty,2009
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The effectiveness of venous thromboembolism prophylaxis interventions in trauma patients: A systematic review and network meta-analysis;Injury;2023-12
2. The trends in venous thromboembolism occurrence and prevention after minimally invasive varicose vein surgery;Phlebology: The Journal of Venous Disease;2023-11-20
3. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgeries and Factor XIa Inhibitors;Medical Sciences;2023-08-11
4. Efficacy and Safety of Rivaroxaban and Enoxaparin for Thromboprophylaxis Among Total Hip Arthroplasty Patients: A Systematic Review and Meta-Analysis;Zeitschrift für Orthopädie und Unfallchirurgie;2023-01-30
5. Current state of the problem of risk assessment and prevention of venous thromboembolic complications after thermal obliteration of superficial veins;Ambulatornaya khirurgiya = Ambulatory Surgery (Russia);2022-11-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3